Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788

European Journal of Pharmacology

Volumn 315, Issue 3, 1996, Pages 339-343

  Demmer, Annette ^a   Dunn, Theresa ^b   Hoof, Torsten ^a   Kubesch, Peter ^a   Tümmler, Burkhard ^a  

^a Medizinisch geriatrisches Zentrum H   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemotherapy; Modulator; Multidrug resistance; P glycoprotein

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; ANTINEOPLASTIC AGENT; CYCLOSPORIN; DAUNORUBICIN; GLYCOPROTEIN P; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG PROTEIN BINDING; HAMSTER; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CRICETINAE; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; P-GLYCOPROTEIN; PIPERIDINES; TRIAZINES;

EID: 0030597326     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00616-4     Document Type: Article

References (26)

1. Busche, R., B. Tümmler, J.R. Riordan and D.F. Cano-Gauci, 1989a, Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance, Mol. Pharmacol. 35, 414.
2. Busche, R., B. Tümmler, D.F. Cano-Gauci and J.R. Riordan, 1989b, Equilibrium, kinetic and photoaffinity labelling studies of daunomycin binding to P-glycoprotein containing membranes of multidrug-resistant Chinese hamster ovary cells, Eur. J. Biochem. 183, 189.
3. Cornwell, M.M., M.M. Gottesman and I.B. Pastan, 1986a, Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells, J. Biol. Chem. 261, 7921.
4. Cornwell, M.M., A.R. Safa, R.L. Felsted, M.M. Gottesman and I. Pastan, 1986b, Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-kDa to 170-kDa protein detected by photoaffinity labelling, Proc. Natl. Acad. Sci. USA 83, 3847.
5. Cornwell, M.M., I. Pastan and M.M. Gottesman, 1987, Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug-binding to P-glycoprotein, J. Biol. Chem. 262, 2166.
6. Cros, S., N. Guilbaud, M. Berlion, T.A. Dunn, G. Regnier, A. Dhainaut, G. Atassi and J.P. Bizzari, 1992, In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model, Cancer Chemother. Pharmacol. 30, 491.
7. Dalton, W.S., T.M. Grogan, P.M. Meltzer, R.J. Schaper, B.G.M. Durie, C.W. Taylor, T.P. Miller and S.E. Salmon, 1989, Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy, J. Clin. Oncol. 7, 415.
8. Ford, J.M. and W.N. Hait, 1990, Pharmacology of drugs that alter multidrug resistance in cancer, Pharmacol. Rev. 42, 155.
9. Gerlach, J.H., N. Kartner, D.R. Bell and V. Ling, 1986, Multidrug resistance, Cancer Surv. 5, 25.
10. Hill, B.T., W.T.A. Van der Graaf, L.K. Hosking, E.G.E. De Vries, N.H. Mulder and R.D.H. Whelan, 1993, Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro, Int. J. Cancer 55, 330.
11. Julia, A.-M., H. Roché, M. Berlion, C. Lucas, G. Milano, J. Robert, J.-P. Bizzari and P. Canal, 1994, Multidrug resistance circumvention by a new triazinoaminopiperidine derivate S9788 in vitro: definition of the optimal schedule and comparison with verapamil, Br. J. Cancer 69, 868.
12. Kartner, N., J.R. Riordan and V. Ling, 1983, Cell surface P-glycoprotein associated with multi-drug resistance in mammalian cell lines, Science 221, 1285.
13. Kartner, N., D. Evernden-Porelle, G. Bradley and V. Ling, 1985, Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316, 820.
14. Léonce, S., A. Pierré, M. Anstett, V. Pérez, A. Genton, J.-P. Bizzari and G. Atassi, 1992, Effects of a new triazinoaminopiperidine derivate on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance, Biochem. Pharmacol. 44, 1707.
15. McBurney, M.W. and G.F. Whitmore, 1974, Isolation and biochemical characterization of folate deficient mutants of Chinese-hamster cells, Cell 2, 173.
16. Merlin, J.-L., A. Guerci, S. Marchal, N. Missoum, C. Ramacci, J.-C. Humbert, T. Tsuruo and O. Guerci, 1994, Comparative evaluation of S9788, verapamil, and cyclosporine a in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies, Blood 84, 262.
17. Miller, T.P., T.M. Grogan, W.S. Dalton, C.M. Spier, R.J. Scheper and S.E. Salmon, 1991, P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose-verapamil, J. Clin. Oncol. 9, 17.
18. Pennock, G.D., W.S. Dalton, W.R. Roeske, C.P. Appleton, K. Mosley, P. Plezia, T.P. Miller and S.E. Salmon, 1991, Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration, J. Natl. Cancer. Inst. 83, 105.
19. Pierré, A., T.A. Dunn, L. Kraus-Berthier, S. Léonce, D. Saint-Dizier, G. Regnier, A. Dhainaut, M. Berlion, J.P. Bizzari and G. Atassi, 1992, In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative, Invest. New Drugs 10, 137.
20. Poupon, M.F., M. Berlion, G. Atassi, T.A. Dunn and J.P. Bizzari, 1992, S9788, a new resistance modulator, enhances the antitumoral activity of vepeside/cis-platinum treatment on a P-glycoprotein positive small cell lung cancer xenograft, Proc. Am. Assoc. Cancer Res. 33, 468.
21. Presant, C.A., P.S. Kennedy, C. Wiseman, K. Gala, A. Bouzaglou, M. Wyres and V. Naessig, 1986, Verapamil reversal of clinical doxorubicin resistance in human cancer, 1986, A Wiltshire Oncology Medical Group Pilot Phase I-II Study, Am. J. Clin. Oncol. 9, 355.
22. Regnier, G, A. Dhainaut, A. Atassi, A. Pierré, S. Léonce and L. Kraus-Berthier, 1992, New triazine derivatives as potent modulators of multidrug resistance, J. Med. Chem. 35, 2481.
23. Riordan, J.R. and V. Ling, 1985, Genetic and biochemical characterization of multidrug resistance, Pharmacol. Ther. 76, 51.
24. Safa, A.R., C.J. Glover, M.B. Meyers, J.L. Biedler and R.L. Felsted, 1986, Vinblastine photoaffinity labelling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells, J. Biol. Chem. 261, 6137.
25. Safa, A.R., C.J. Glover, J.L. Sewell, M.B. Meyers, J.L. Biedler and R.L. Felsted, 1987, Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers, J. Biol. Chem. 262, 7884.
26. Twentyman, P.R., 1992, Cyclosporins as drug resistance modifiers, Biochem. Pharmacol. 43, 109.